Philip Laws
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (14)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
The risk of serious infection in people with severe psoriasis treated with infliximab was examined in a cohort study using real-world data from BADBIR. The propensity score method and inverse probability of treatment weights were used to balance covariates across treatment groups. An Andersen–Gill recurrent Cox model was used to estimate hazard ratios for comparisons with infliximab. Our findings suggest that infliximab is associated with an increased risk of serious infection vs. adalimumab, secukinumab, ustekinumab and standard treatments.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2024
Collaborators (18)
Helena Marzo-Ortega
University of Leeds
Richard Parker
-
Duc Binh Phan
Lecturer
VinUniversity
Nick J. Reynolds
Professor
Newcastle University
Catherine Smith
King’s College London
Kulveer Mankia
Professor
University of Leeds
Zenas Z N Yiu
The University of Manchester
Philip Helliwell
Professor of Clinical Rheumatology
University of Leeds
Sayam Dubash
-
Richard B Warren
Manchester University NHS Foundation Trust
Ian Evans
University of Manchester
Oras Alabas
The University of Manchester
Gabriel Rogers
The University of Manchester
andrew barr
Honorary Senior Lecturer
University of Leeds
Dennis McGonagle
University of Leeds
Paul Devakar Yesudian
Betsi Cadwaladr University Health Board
Mark Lunt
Reader in Medical Statistics
The University of Manchester
Olivia Hughes
Cardiff University
Make your next move.
Prepare your application
Review drafts before you send them.